GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Creative Medical Technology
Shares of Creative Medical, a biotech company working in the field of regenerative medicine, are extremely volatile. Their price reflects speculative hopes for a breakthrough in their scientific research rather than fundamentals.
Share prices of companies in the market segment - Stem_cells
Creative Medical Technology is a biotech company developing stem cell-based therapies for erectile dysfunction and other conditions. We've categorized it under "Stem Cells." The chart below shows the dynamics of the regenerative medicine sector.
Broad Market Index - GURU.Markets
Creative Medical Technology is a biotech company developing stem cell-based therapies for a variety of conditions, including erectile dysfunction. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Creative Medical compares to it.
Change in the price of a company, segment, and market as a whole per day
CELZ - Daily change in the company's share price Creative Medical Technology
Creative Medical Technology's daily share price fluctuations reflect the extreme volatility inherent in regenerative medicine companies. This metric is a measure of its sensitivity to clinical trial data for its drugs.
Daily change in the price of a set of shares in a market segment - Stem_cells
Creative Medical Technology operates in the field of regenerative medicine, which implies high volatility related to research results. The chart below shows the average daily risk in the stem cell sector. It serves as a benchmark for comparing CELZ stock performance.
Daily change in the price of a broad market stock, index - GURU.Markets
Creative Medical Technology is a biotech company working in the field of regenerative medicine using stem cells. Its shares are a bet on scientific revolution. Their high volatility, driven by research, is part of the dynamic nature of the innovation sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Creative Medical Technology
Creative Medical Technology Holdings' year-to-date performance tells the story of its diversified portfolio of regenerative medicine developments. Its 12-month market cap depends on progress in its programs using stem cells to treat erectile dysfunction, stroke, and other conditions, making it a high-risk but potentially breakthrough stock.
Annual dynamics of market capitalization of the market segment - Stem_cells
As an early-stage biotech company, Creative Medical is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about the clinical trials of its cell therapy. Its stock price will reflect investors' speculative belief in its potential.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Creative Medical Technology is a venture bet on regenerative medicine. Its stock price has nothing to do with the economy, but rather reflects investors' faith in its stem cell-based research. Positive clinical data could trigger explosive growth, defying any market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Creative Medical Technology
Creative Medical is a biotech company working in the field of regenerative medicine. Being an early-stage company, its monthly valuation is based on the potential of its scientific platform. News about progress in preclinical and early clinical trials are the main drivers.
Monthly dynamics of market capitalization of the market segment - Stem_cells
Creative Medical Technology Holdings is a commercial- and clinical-stage biotech company focused on regenerative medicine using stem cells. Its sector dynamics, shown in the chart, reflect the risks of R&D. Against this backdrop, one can assess how its developments in erectile dysfunction and stroke treatments are progressing in the market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Creative Medical Technology operates in the fields of regenerative medicine and stem cells. Its shares are a bet on future medical breakthroughs. The chart will show high volatility and a weak correlation with the market, as the stock reflects news about clinical trials rather than general economic trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Creative Medical Technology
Creative Medical Technology develops stem cell-based therapies. Its weekly stock price, typical for early-stage biotech, is entirely dependent on progress in clinical trials.
Weekly dynamics of market capitalization of the market segment - Stem_cells
Creative Medical Technology operates in the fields of regenerative medicine and stem cells. The chart clearly demonstrates whether the sharp weekly stock price movements are the result of unique company news or reflect general optimism or pessimism in the biotech sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Creative Medical Technology is a biotech company whose stock moves in sync with clinical trial news. This chart is a great way to see how its weekly fluctuations are disconnected from overall market trends. Is the company living its own life, or is it being affected by the global sell-off?
Market capitalization of the company, segment and market as a whole
CELZ - Market capitalization of the company Creative Medical Technology
The chart for Creative Medical Technology visualizes the promise of regenerative medicine. The market cap of this company, which develops stem cell-based therapies for erectile dysfunction and other conditions, reflects investors' faith in the potential of its scientific research.
CELZ - Share of the company's market capitalization Creative Medical Technology within the market segment - Stem_cells
Creative Medical Technology is a biotech company developing stem cell-based therapies for a variety of conditions, including erectile dysfunction and stroke. In the cutting-edge stem cell segment, its market capitalization reflects the potential of its research programs. The company's market capitalization reflects the success of its clinical trials.
Market capitalization of the market segment - Stem_cells
Creative Medical Technology operates in the field of regenerative medicine. How big is this industry? The chart below is a barometer of the entire stem cell sector. Its extreme volatility reflects both the enormous promise of treating a wide range of diseases and the high risks inherent in this futuristic field.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Creative Medical Technology chart shows how the market values developments in regenerative medicine. The market cap of this company, which uses stem cells to treat erectile dysfunction and stroke, is a pure venture bet. This chart is full of scientific risk and potential breakthroughs.
Book value capitalization of the company, segment and market as a whole
CELZ - Book value capitalization of the company Creative Medical Technology
For Creative Medical Technology, a company focused on regenerative medicine, book value is its tangible foundation: laboratories, rights to stem cell-based technologies, and financial reserves. The chart below shows how the company built this physical and scientific foundation.
CELZ - Share of the company's book capitalization Creative Medical Technology within the market segment - Stem_cells
Creative Medical Technology Holdings is a regenerative medicine company. Its main assets are laboratories and partner clinics where its stem cell-based technologies are developed and applied. The chart shows the company's control over this cutting-edge medical infrastructure.
Market segment balance sheet capitalization - Stem_cells
Creative Medical Technology is a cell therapy company. Pharmaceuticals, as the chart shows, are capital-intensive. Creative Medical is a prime example. Its business requires the construction of its own, highly complex and expensive laboratories.
Book value of all companies included in the broad market index - GURU.Markets
Creative Medical's assets are not clinics, but a portfolio of patents and developments in regenerative medicine using stem cells to treat conditions such as erectile dysfunction and stroke. Its book value reflects its scientific potential.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Creative Medical Technology
Creative Medical Technology develops stem cell-based therapies. Its market capitalization reflects its scientific prowess. The chart illustrates the risks and promises associated with this area of regenerative medicine.
Market to book capitalization ratio in a market segment - Stem_cells
Creative Medical Technology is a biotech company specializing in regenerative medicine and cell therapy. Its value is based on the potential of its scientific developments. The chart shows how investors value its patent portfolio and clinical programs.
Market to book capitalization ratio for the market as a whole
Creative Medical Technology operates in the field of regenerative medicine. Its valuation is based on the potential of its therapies to treat various diseases. This chart illustrates how, in biotech, investors' hopes for the future create market value unrelated to current tangible assets.
Debts of the company, segment and market as a whole
CELZ - Company debts Creative Medical Technology
Creative Medical Technology is developing stem cell-based therapies. Biotech companies in the development stage are entirely dependent on external funding. This chart shows how the company is raising capital to support its various, but very expensive, clinical programs in hopes of commercializing its innovative treatments.
Market segment debts - Stem_cells
Creative Medical Technology is a biotechnology company working in the field of regenerative medicine using stem cells. Its developments are in the early stages. This chart shows its financial position and its reliance on equity capital to fund its research programs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Creative Medical Technology
Creative Medical Technology is a biotech company working in cell therapy. This chart shows its financial structure. As with most companies in this field at the development stage, debt is a huge risk. Funding must come from equity.
Market segment debt to market segment book capitalization - Stem_cells
Creative Medical Technology develops stem cell-based treatments for various conditions, including erectile dysfunction. This is a promising area, but requires further proof. The chart shows the overall debt burden in the biotech sector, giving investors insight into how the company finances its lengthy and expensive clinical trials.
Debt to book value of all companies in the market
Creative Medical Technology is a company working in the field of regenerative medicine and cell therapy. Being in the research stage, it relies entirely on equity capital. This chart highlights the gap between the world of cutting-edge science, funded by investors, and the world of established businesses, which rely on debt markets for growth.
P/E of the company, segment and market as a whole
P/E - Creative Medical Technology
For Creative Medical Technology, a stem cell company, the P/E ratio is irrelevant. The company doesn't have stable profits. Its valuation on this chart is arbitrary. Its true value is determined by the potential of its scientific developments in regenerative medicine.
P/E of the market segment - Stem_cells
Creative Medical Technology is a commercial biotechnology company specializing in regenerative medicine and cell therapy for the treatment of various diseases. This chart shows the average valuation for the sector, providing investors with context for evaluating this company's portfolio and technologies.
P/E of the market as a whole
Creative Medical Technology is a biotech company working in the field of regenerative medicine using stem cells. Its valuation is a pure bet on the success of its scientific research. It is in no way tied to the general economic cycles illustrated by this chart. Its fate is decided in clinics and the minds of regulators.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Creative Medical Technology
Creative Medical Technology is a biotech company developing stem cell-based therapies for various conditions, including erectile dysfunction and stroke. This chart reflects investor expectations for its clinical programs in regenerative medicine. The valuation is based on the potential of its developments.
%20P%2FE%20Creative%20Medical%20Technology&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Creative-Medical-Technology&v=1772513410538 "Chart of the company's future (projected) P/E Creative Medical Technology")
Future (projected) P/E of the market segment - Stem_cells
Creative Medical Technology is a biotech company focused on regenerative medicine and stem cells. Its valuation relative to other biotech companies reflects investor sentiment about its developments in areas such as erectile dysfunction and stroke treatment. This reflects how the market assesses the risks and potential of its clinical programs.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Stem_cells&v=1772513410588 "Future (projected) P/E graph of the market segment - Stem_cells")
Future (projected) P/E of the market as a whole
Creative Medical Technology develops stem cell-based therapies for erectile dysfunction, stroke, and other conditions. This is a cutting-edge and risky area of medicine. This chart reflects investors' overall risk appetite. For biotech companies working with cell technologies, a positive market environment is key to raising capital for research.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513410657 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Creative Medical Technology
Creative Medical Technology is a biotechnology company focused on regenerative medicine and the development of stem cell-based therapies for the treatment of various diseases. The financial indicators shown in the chart represent investments in its clinical programs in areas such as urology and neurology.
Profit of companies in the market segment - Stem_cells
Creative Medical Technology is another company working in the promising field of stem cells and regenerative medicine. This chart shows the overall profitability (or loss) of the stem cell sector. It helps assess how far the industry has progressed from scientific discovery to the development of cost-effective treatments.
Overall market profit
Creative Medical Technology develops therapeutic solutions based on stem cells. It is an early-stage biotech company. Its future depends on the results of clinical trials. The macroeconomic situation, reflected in this chart, affects it solely through the availability of venture capital.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Creative Medical Technology
Creative Medical Technology is a biotech company specializing in stem cell therapy. Its future profit forecast depends on the success of clinical trials and regulatory approval. This chart shows how analysts assess the potential of its developments in regenerative medicine.
%20profit%20of%20the%20company%20Creative%20Medical%20Technology&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Creative-Medical-Technology&v=1772513410706 "Graph of future (projected) profit of the company Creative Medical Technology")
Future (predicted) profit of companies in the market segment - Stem_cells
Creative Medical Technology is a biotech company developing stem cell-based treatments for conditions such as erectile dysfunction and stroke. This chart shows forecasts for the stem cell sector. It illustrates the high risk and enormous potential of regenerative medicine in solving complex medical problems.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Stem_cells&v=1772513410721 "Graph of future (predicted) profits of companies in a market segment - Stem_cells")
Future (predicted) profit of the market as a whole
For Creative Medical Technology, which works in the field of regenerative medicine, this chart is important for the investment climate. Expectations of economic growth make it easier to raise capital for expensive stem cell clinical research. During downturns, investors are less risk-averse.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513410735 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Creative Medical Technology
Creative Medical Technology develops stem cell-based therapies. With no commercial products, its valuation, as shown in this chart, is based entirely on investors' faith in its scientific developments.
P/S market segment - Stem_cells
Creative Medical Technology is a biotech company developing stem cell-based therapies for erectile dysfunction and other conditions. This chart shows the average valuation in the stem cell sector. It reflects investor expectations for the potential of regenerative medicine to solve complex medical problems.
P/S of the market as a whole
Creative Medical Technology Holdings is a biotech company developing stem cell-based therapies for erectile dysfunction, stroke, and other conditions. The company's valuation is based on expectations for its clinical programs. This chart clearly illustrates the gap between estimated future potential and the market's current revenue valuation.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Creative Medical Technology
Creative Medical Technology develops stem cell-based therapies for the treatment of various conditions, including erectile dysfunction. The company's valuation is based on the future potential of its developments. The chart reflects investors' faith in regenerative medicine and the commercial prospects of its programs.
%20P%2FS%20Creative%20Medical%20Technology&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Creative-Medical-Technology&v=1772513410797 "The graph of the company's future (projected) P/S Creative Medical Technology")
Future (projected) P/S of the market segment - Stem_cells
Creative Medical Technology is a biotech company developing stem cell-based treatments for conditions such as erectile dysfunction and stroke. This chart shows how investors assess the commercial potential of its regenerative medicine developments.
%20P%2FS%20market%20segment%20graph%20-%20Stem_cells&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Stem_cells&v=1772513410813 "Future (projected) P/S market segment graph - Stem_cells")
Future (projected) P/S of the market as a whole
This chart reflects expectations for the regenerative medicine market. For Creative Medical Technology, a cell therapy company, this reflects investor appetite for innovation. Market optimism allows them to fund the development of treatments based on a patient's own stem cells.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513410834 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Creative Medical Technology
Creative Medical Technology is a biotechnology company developing stem cell-based therapeutics for erectile dysfunction and other conditions. This chart reflects licensing revenue. Future revenue is dependent on the success of clinical trials and the commercialization of its cell technologies.
Sales of companies in the market segment - Stem_cells
Creative Medical Technology is a biotech company specializing in stem cell-based regenerative medicine. This chart shows the growth in this sector. Creative Medical is developing therapies for erectile dysfunction, stroke, and other conditions, harnessing the regenerative potential of the body's own cells.
Overall market sales
Creative Medical Technology Holdings develops stem cell-based therapeutic solutions. Its market capitalization depends on progress in clinical trials. The overall economic environment, shown in this chart, influences the availability of capital to finance cutting-edge but risky areas of regenerative medicine.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Creative Medical Technology
Creative Medical Technology Holdings is a biotechnology company developing stem cell-based therapies for erectile dysfunction and other conditions. This graph reflects analyst expectations for the success of the company's clinical programs in regenerative medicine.
%20sales%20of%20the%20company%20Creative%20Medical%20Technology&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Creative-Medical-Technology&v=1772513410928 "Schedule of future (projected) sales of the company Creative Medical Technology")
Future (projected) sales of companies in the market segment - Stem_cells
Creative Medical Technology is developing stem cell-based treatments. This graph shows expectations for the entire cell therapy sector. It reflects the strong interest in regenerative medicine for treating a wide range of conditions, from erectile dysfunction to stroke.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Stem_cells&v=1772513410939 "Schedule of future (projected) sales of companies in the market segment - Stem_cells")
Future (projected) sales of the market as a whole
Creative Medical Technology Holdings is a biotechnology company specializing in regenerative medicine using stem cells to treat various diseases. Its valuation depends on the success of its clinical programs. This graph, reflecting the state of the economy, affects the availability of capital required for expensive cell therapy research.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513410944 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Creative Medical Technology
Creative Medical Technology is developing stem cell-based therapies to treat various conditions, including erectile dysfunction. This chart shows the company's financial performance during the clinical trials phase. Negative values represent investments in regenerative medicine, which may offer new treatment approaches.
Market segment marginality - Stem_cells
Creative Medical Technology develops stem cell-based treatments for conditions such as erectile dysfunction and stroke. For a clinical-stage biotech company, this chart is an indicator of potential. It shows the average profitability in the sector, which the company could aspire to if its therapeutic programs are successful.
Market marginality as a whole
Creative Medical Technology is a biotechnology company specializing in regenerative medicine and cell therapy. This overall market profitability chart is irrelevant to the company. Its potential lies in its scientific developments. Success depends on clinical trial data and the ability to commercialize its innovative approaches.
Employees in the company, segment and market as a whole
Number of employees in the company Creative Medical Technology
Creative Medical Technology is a biotech company working in the field of regenerative medicine using stem cells. This graphic shows a small team focused on research and clinical trials of their therapeutic approaches.
Share of the company's employees Creative Medical Technology within the market segment - Stem_cells
Creative Medical Technology Holdings works in the field of regenerative medicine, using stem cells to treat a variety of diseases. This chart shows the percentage of leading biologists, clinicians, and cell therapy specialists the company attracts in this innovative field. It reflects its concentration of unique scientific talent.
Number of employees in the market segment - Stem_cells
Creative Medical Technology is a biotech company working in the field of regenerative medicine and developing stem cell-based therapies. This graph shows how cutting-edge research is creating treatments that can do more than just alleviate symptoms, but also repair damaged tissue, requiring elite scientists.
Number of employees in the market as a whole
Creative Medical Technology, working in the field of stem cells, is another representative of the medicine of the future. This graph shows the overall picture, but its qualitative growth depends on such innovators. Investments in regenerative medicine today create high-tech jobs and new treatments tomorrow.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Creative Medical Technology (CELZ)
Creative Medical Technology is a biotech company specializing in cell therapy (stem cells). This chart represents the net intellectual capital valuation. The company's value is based on market expectations for its development pipeline (for example, for treating erectile dysfunction). The chart shows how highly the market values this scientific potential.
%20of%20the%20company%20Creative%20Medical%20Technology%20(CELZ)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Creative-Medical-Technology-CELZ&v=1772513411125 "Chart of market capitalization per employee (in thousands of dollars) of the company Creative Medical Technology (CELZ)")
Market capitalization per employee (in thousands of dollars) in the market segment - Stem_cells
Creative Medical Technology develops stem cell-based treatments. In regenerative medicine, market capitalization reflects confidence in scientific potential. The chart shows the market premium paid for each scientist on the team, reflecting expectations for their developments in the treatment of erectile dysfunction and stroke.
%20by%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Stem_cells&v=1772513411129 "Market capitalization per employee (in thousands of dollars) by market segment - Stem_cells")
Market capitalization per employee (in thousands of dollars) for the overall market
Creative Medical Technology Holdings is a biotech company developing stem cell-based therapies. This chart shows the average market value generated by one specialist, highlighting the market's hopes for regenerative medicine.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513411144 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Creative Medical Technology (CELZ)
Creative Medical Technology is a biotech company working with stem cells. The company has no commercial products. This chart shows the net loss per employee. It reflects how much the company invests in each scientist for R&D.
%20Chart%20Creative%20Medical%20Technology%20(CELZ)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Creative-Medical-Technology-CELZ&v=1772513411157 "Company Profit Per Employee (in thousands of dollars) Chart Creative Medical Technology (CELZ)")
Profit per employee (in thousands of dollars) in the market segment - Stem_cells
Creative Medical Technology Holdings is a biotech company developing cell therapies for various conditions, including erectile dysfunction and stroke. Being in the research stage, it is likely to report negative earnings per employee, reflecting its high investment in its research team and clinical trials.
%20in%20the%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Stem_cells&v=1772513411169 "Chart of profit per employee (in thousands of dollars) in the market segment - Stem_cells")
Profit per employee (in thousands of dollars) for the market as a whole
Creative Medical Technology (CELZ) is a clinical-stage biotech company developing stem cell-based therapies for the treatment of stroke and erectile dysfunction. This is an R&D business. This chart shows the market average dollar return per employee. For CELZ (which is not yet profitable), this is a benchmark: in biotech, IP can significantly exceed this average.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513411177 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Creative Medical Technology (CELZ)
Creative Medical Technology is a biotech company working in the field of regenerative medicine. This graph is a predictor of the future. It reflects the potential for successful clinical trials to lead to commercialization of the therapy and significant growth in revenue per employee.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Creative-Medical-Technology-CELZ&v=1772513411195 "Sales chart per company employee Creative Medical Technology (CELZ)")
Sales per employee in the market segment - Stem_cells
Creative Medical Technology is a biotech company working in the field of regenerative medicine using stem cells. The company is in the R&D stage. This chart shows the average revenue per employee in this segment. It serves as a productivity benchmark for commercial pharmaceutical companies and helps evaluate the effectiveness of CELZ's scientific team.
Sales per employee for the market as a whole
Creative Medical Technology is a biotech company developing cell therapy (stem cells) for the treatment of various diseases, including erectile dysfunction. The company has no commercial revenue. This metric is irrelevant. Their entire value lies in the potential of their R&D team.
Short shares by company, segment and market as a whole
Shares shorted by company Creative Medical Technology (CELZ)
Creative Medical Technology is a biotech "micro-cap" betting on stem cell therapy for erectile dysfunction. This is a highly speculative field. This chart shows the bets that it's "science fiction." The bears believe the company lacks solid clinical data and its technology doesn't work.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Creative-Medical-Technology-CELZ&v=1772513411253 "Short Shares Chart for the Company Creative Medical Technology (CELZ)")
Shares shorted by market segment - Stem_cells
Creative Medical Technology (CELZ) is a biotech company developing stem cell-based therapies for erectile dysfunction and stroke. This chart reflects the total short position in the cell therapy sector. High values indicate general investor skepticism about the safety, efficacy, or commercialization of these complex treatments.
Shares shorted by the overall market
Creative Medical (CELZ) is a clinical-stage biotech company. Its survival depends entirely on access to capital markets. When this market pessimism indicator rises, it signals a "venture winter." Investors panic and flee unprofitable biotechs, fearing CELZ will be unable to raise capital.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Creative Medical Technology (CELZ)
Creative Medical Technology (CELZ) focuses on regenerative medicine, using stem cells to treat various conditions, including erectile dysfunction. This is a cutting-edge field. This indicator measures the strength of speculative moves. It shows when stocks are "overheated" (above 70) on trial news or "oversold" (below 30) due to a lack of news.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Creative-Medical-Technology-CELZ&v=1772513411361 "RSI 14 indicator chart for the company's stock Creative Medical Technology (CELZ)")
RSI 14 Market Segment - Stem_cells
Creative Medical Technology is a biotech company working in the field of regenerative medicine. It develops stem cell-based therapies for conditions such as stroke and erectile dysfunction. This chart tracks the collective sentiment in the niche stem cell storage and therapy sector. It helps us understand whether CELZ's momentum is part of the overall hype.
RSI 14 for the overall market
Creative Medical (CELZ) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CELZ (Creative Medical Technology)
Creative Medical Technology is a biotech company developing stem cell-based treatments for conditions such as erectile dysfunction (CaverStem) and stroke. This chart shows the average analyst forecast. Their targets are based on clinical data and the potential of regenerative medicine.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CELZ-Creative-Medical-Technology&v=1772513411411 "A chart showing analyst consensus forecasts for the expected stock price. CELZ (Creative Medical Technology)")
The difference between the consensus estimate and the actual stock price CELZ (Creative Medical Technology)
Creative Medical Tech is a biotech company working in the field of regenerative medicine. It uses stem cells to treat conditions such as erectile dysfunction. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their faith in this R&D approach.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CELZ-Creative-Medical-Technology&v=1772513411417 "A chart showing the difference between the consensus forecast and the actual stock price. CELZ (Creative Medical Technology)")
Analyst consensus forecast for stock prices by market segment - Stem_cells
Creative Medical Technology is a biotech company operating at the cutting edge of science. It develops stem cell-based therapies for the treatment of strokes and erectile dysfunction. This chart shows general expectations for the stem cell sector. It reflects whether experts believe regenerative medicine will be commercially successful.
Analysts' consensus forecast for the overall market share price
Creative Medical Technology (CELZ) is an R&D holding company focused on regenerative medicine. They develop stem cell-based treatments for conditions as diverse as diabetes and erectile dysfunction. This chart shows the overall risk appetite, reflecting the degree to which investors are willing to invest in speculative R&D platforms.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Creative Medical Technology
Creative Medical is a stem cell incubator. They don't have a single focus; they develop platforms (CaverStem, FemCelz, ImmCelz) for treating lifestyle (erectile dysfunction) and serious (stroke) diseases using stem cells. This chart is a pure indicator of their R&D. It reflects a speculative assessment of their (very broad and risky) pipeline.
AKIMA Market Segment Index - Stem_cells
Creative Medical (CELZ) is a biotech company specializing in regenerative medicine. They develop stem cell-based treatments for such diverse areas as stroke, diabetes, and erectile dysfunction. This chart shows the segment's average index, helping investors assess how this portfolio's approach to stem cells compares to the industry average.
The AKIM Index for the overall market
Creative Medical Technology is a biotech company using stem cells to treat urological, orthopedic, and neurological conditions. This chart, which reflects the market average, provides a macro backdrop. It helps assess how CELZ, a regenerative medicine company, compares to overall economic trends.
